These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 33092896)

  • 1. An Up-to-date Assessment of US Prostate Cancer Incidence Rates by Stage and Race: A Novel Approach Combining Multiple Imputation with Age and Delay Adjustment.
    Cook MB; Hurwitz LM; Geczik AM; Butler EN
    Eur Urol; 2021 Jan; 79(1):33-41. PubMed ID: 33092896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changing Incidence of Metastatic Prostate Cancer by Race and Age, 1988-2015.
    Dall'Era MA; deVere-White R; Rodriguez D; Cress R
    Eur Urol Focus; 2019 Nov; 5(6):1014-1021. PubMed ID: 29735368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Past, Current, and Future Incidence Rates and Burden of Metastatic Prostate Cancer in the United States.
    Kelly SP; Anderson WF; Rosenberg PS; Cook MB
    Eur Urol Focus; 2018 Jan; 4(1):121-127. PubMed ID: 29162421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rates and trends in stage-specific prostate cancer incidence by age and race/ethnicity, 2000-2017.
    Cao Y; Zhang W; Li Y; Fu J; Li H; Li X; Gao X; Zhang K; Liu S
    Prostate; 2021 Oct; 81(14):1071-1077. PubMed ID: 34320230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stage-specific incidence rates and trends of prostate cancer by age, race, and ethnicity, United States, 2004-2014.
    Li J; Siegel DA; King JB
    Ann Epidemiol; 2018 May; 28(5):328-330. PubMed ID: 29678312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disparities and Trends in Genitourinary Cancer Incidence and Mortality in the USA.
    Schafer EJ; Jemal A; Wiese D; Sung H; Kratzer TB; Islami F; Dahut WL; Knudsen KE
    Eur Urol; 2023 Jul; 84(1):117-126. PubMed ID: 36566154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contemporary Trends in the Incidence of Metastatic Prostate Cancer Among US Men: Results from Nationwide Analyses.
    Dalela D; Sun M; Diaz M; Karabon P; Seisen T; Trinh QD; Menon M; Abdollah F
    Eur Urol Focus; 2019 Jan; 5(1):77-80. PubMed ID: 28753893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Racial disparities in late-stage prostate cancer: a SEER analysis 2005-2015.
    Rodriguez S; Sparks AD; Zhou H; Amdu RL; Lin J
    Can J Urol; 2019 Oct; 26(5):9946-9951. PubMed ID: 31629445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term Trends in Prostate Cancer Incidence by Stage at Diagnosis in Japan Using the Multiple Imputation Approach, 1993-2014.
    Saito E; Hori M; Matsuda T; Yoneoka D; Ito Y; Katanoda K
    Cancer Epidemiol Biomarkers Prev; 2020 Jun; 29(6):1222-1228. PubMed ID: 32169995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increase in the Annual Rate of Newly Diagnosed Metastatic Prostate Cancer: A Contemporary Analysis of the Surveillance, Epidemiology and End Results Database.
    Bandini M; Mazzone E; Preisser F; Nazzani S; Zaffuto E; Marchioni M; Tian Z; Pompe RS; Tilki D; Graefen M; Shariat SF; Montorsi F; Saad F; Briganti A; Karakiewicz P
    Eur Urol Oncol; 2018 Sep; 1(4):314-320. PubMed ID: 31100253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Annual Report to the Nation on the Status of Cancer, part II: Recent changes in prostate cancer trends and disease characteristics.
    Negoita S; Feuer EJ; Mariotto A; Cronin KA; Petkov VI; Hussey SK; Benard V; Henley SJ; Anderson RN; Fedewa S; Sherman RL; Kohler BA; Dearmon BJ; Lake AJ; Ma J; Richardson LC; Jemal A; Penberthy L
    Cancer; 2018 Jul; 124(13):2801-2814. PubMed ID: 29786851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Annual Report to the Nation on the Status of Cancer, part I: National cancer statistics.
    Cronin KA; Lake AJ; Scott S; Sherman RL; Noone AM; Howlader N; Henley SJ; Anderson RN; Firth AU; Ma J; Kohler BA; Jemal A
    Cancer; 2018 Jul; 124(13):2785-2800. PubMed ID: 29786848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent decline in prostate cancer incidence in the United States, by age, stage, and Gleason score.
    Herget KA; Patel DP; Hanson HA; Sweeney C; Lowrance WT
    Cancer Med; 2016 Jan; 5(1):136-41. PubMed ID: 26628287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variations in Age-Adjusted Prostate Cancer Incidence Rates by Race and Ethnicity After Changes in Prostate-Specific Antigen Screening Recommendation.
    Lai SM; Keighley J; Garimella S; Enko M; Parker WP
    JAMA Netw Open; 2022 Nov; 5(11):e2240657. PubMed ID: 36342715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Choice of imputation method for missing metastatic status affected estimates of metastatic prostate cancer incidence.
    Westerberg M; Beckmann K; Gedeborg R; Irenaeus S; Holmberg L; Garmo H; Stattin P
    J Clin Epidemiol; 2023 Mar; 155():22-30. PubMed ID: 36538980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate Cancer Incidence 5 Years After US Preventive Services Task Force Recommendations Against Screening.
    Jemal A; Culp MB; Ma J; Islami F; Fedewa SA
    J Natl Cancer Inst; 2021 Jan; 113(1):64-71. PubMed ID: 32432713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disparities in Hepatocellular Carcinoma Incidence, Stage, and Survival: A Large Population-Based Study.
    Flores YN; Datta GD; Yang L; Corona E; Devineni D; Glenn BA; Bastani R; May FP
    Cancer Epidemiol Biomarkers Prev; 2021 Jun; 30(6):1193-1199. PubMed ID: 33737301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Racial/Ethnic Disparities in Prostate Cancer Incidence, Distant Stage Diagnosis, and Mortality by U.S. Census Region and Age Group, 2012-2015.
    Iyengar S; Hall IJ; Sabatino SA
    Cancer Epidemiol Biomarkers Prev; 2020 Jul; 29(7):1357-1364. PubMed ID: 32303533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in Incidence of Metastatic Prostate Cancer in the US.
    Desai MM; Cacciamani GE; Gill K; Zhang J; Liu L; Abreu A; Gill IS
    JAMA Netw Open; 2022 Mar; 5(3):e222246. PubMed ID: 35285916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Racial differences in patterns of treatment among men diagnosed with de novo advanced prostate cancer: A SEER-Medicare investigation.
    Beebe-Dimmer JL; Ruterbusch JJ; Cooney KA; Bolton A; Schwartz K; Schwartz AG; Heath E
    Cancer Med; 2019 Jun; 8(6):3325-3335. PubMed ID: 31094098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.